Real-time stock price, financial statements, consensus target price, insider trading, and technical analysis for Panion & BF Biotech Inc. (1760:TWSE), powered by AI.
Panion & BF Biotech Inc. is currently trading at $59.90. View real-time AI analysis on Alpha Lenz.
View the latest insider trading data for Panion & BF Biotech Inc. on Alpha Lenz.
View Panion & BF Biotech Inc.'s valuation metrics on Alpha Lenz.
“Panion & BF Biotech Inc.'s ROE is 9.8%. Explore profitability and growth together.”
Ask for details →Panion & BF Biotech Inc. is a specialized company in the biotechnology sector. Its primary purpose is to develop, produce, and market pharmaceutical products and biotechnology-related health solutions. The company's expertise lies in the fields of biologics and pharmaceuticals, targeting critical areas such as oncology, vaccines, and rare diseases. Biotech firms like Panion & BF Biotech play significant roles in advancing medical science and improving patient health outcomes. By focusing on innovative therapeutic options and leveraging cutting-edge biotechnology techniques, they contribute to the development of new medicines and treatments that address unmet medical needs. In the financial markets, biotechnology companies are pivotal for their potential impact on healthcare innovation, often drawing interest from investors focused on long-term growth in the health sciences sector. With an emphasis on research and development, Panion & BF Biotech aids in expanding the potential solutions available for complex health challenges globally.
“Panion & BF Biotech Inc.'s ROE is 9.8%. Explore profitability and growth together.”
Ask for details →Panion & BF Biotech Inc. (ticker: 1760) is a company listed on TWSE in the Healthcare sector (Biotechnology).
The current price is 59.9 with a P/E ratio of -x and P/B of -x.
ROE is 9.81% and operating margin is 14.96%. Annual revenue is $2.1B.